Search results
Piramal Group is a leading Global Business Conglomerate with diverse interests in Pharma, Financial Services, Real Estate, and Glass Packaging; nurturing social initiatives through Piramal Foundation.
The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate . History. In the early 1980s, Ajay Piramal took over the reins of Piramal Group.
Since the late 1980s, Piramal Group has evolved from a textile-centric business to a diversified organization, which operates across sectors such as pharma, health care information management, financial services, specialty glass packaging and real estate.
Discover the story behind Piramal Enterprises Ltd., a beacon of innovation and excellence in the global business landscape.
Piramal Group is a global business conglomerate with diverse interests in pharma, financial services and real estate. The Group has offices in over 30 countries and a global brand presence in more than 100 markets, and operates with over 10,000 people worldwide from 21 diverse nationalities. Mr.
Piramal Group is committed in achieving excellence by practicing our core values of Knowledge, Action, Care, & Impact. View all 2,775 employees.
Piramal Pharma Limited (PPL) offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries.
One of India Inc’s leading voices, Piramal is in no mood to relax but aims to focus more on “making a difference” through the philanthropic arm of the Piramal Group—Piramal Foundation.
Ajay Gopikisan Piramal (born 3 August 1955) is an Indian billionaire businessman, and the chairman of the Piramal Group, a conglomerate with interests in pharmaceutical, financial services, real estate, healthcare analytics and glass packaging.
Oct 7, 2021 · Indian conglomerate Piramal Enterprises Ltd (PEL) said on Thursday it was demerging its pharmaceutical business and listing it as a separate entity as part of a move to simplify its corporate...
